ScanDiags AG

Zurich/Wallisellen, Switzerland (R&D group ScanDiags AG) and Vancouver, Canada (ScanDiags Health Technologies Inc.)  All Switzerland companies → — Founded 2015
Imaging AI Specialist Specialty-Focused AI
Neurosurgery Orthopedics Radiology
Radiology & Imaging AI
Undisclosed (partnered with Omnia Global for business development, financing, and market development)

Products

ScanDiags Ortho L-Spine MR-Q
ScanDiags AG
Radiology & Imaging AI
ScanDiags Ortho L-Spine MR-Q is an FDA-cleared AI-powered Software as a Medical Device (SaMD) that provides quantitative analysis and visualization of lumbar spine MRI images. It uses deep learning for semi-automatic segmentation and measurement of anatomical structures, generating radiologist-reviewed reports for PACS integration.

See all 1 product →

About ScanDiags AG

ScanDiags AG is a healthcare AI company that has developed ImagoPlus, an innovative software platform for medical imaging. This platform specializes in the active interpretation of magnetic resonance imaging (MRI) by providing immediate data detection, quantification, and clinical insights. For physicians, ImagoPlus delivers standardized diagnostic reports through a fully automated process, which aims to alleviate the burden on clinicians at the point of care, enhance workflow capacity, and contribute to reducing overall healthcare system costs.

The ImagoPlus platform is designed to be compatible with all MRI hardware and integrates seamlessly into existing radiology operations. Currently, its Musculoskeletal (MSK) Suite is fully operational, featuring a Lumbar Spine module, with Knee, Shoulder, and Hip modules nearing completion for subsequent launches. ScanDiags AG is also actively expanding the ImagoPlus platform to include Neurological and Cardiovascular pathology suites. The company has successfully completed four clinical trials in Switzerland and is pursuing regulatory clearance from the US Food and Drug Administration (FDA), with a validation study in the United States being finalized for a 510k submission.

Focus Areas

Medical imaging MRI analysis AI-driven augmented diagnosis musculoskeletal conditions neurological pathology cardiovascular pathology

Business Intelligence

Key InvestorsOMNIA Global (strategic partner)
PartnershipsOMNIA Global (February 2024), Gesund Partners (November 2022)
TechnologyImagoPlus™ software platform, AI-driven augmented diagnosis, deep learning, image analysis, regression-based machine learning methods, manufacturer-independent, PACS-independent, parameter-independent
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Core Specialization: Medical Imaging & MRI Analysis
ScanDiags AG specializes in the active interpretation of Magnetic Resonance Imaging (MRI) data, providing immediate detection, quantification, and clinical insights. Their ImagoPlusu2122 platform is designed to enhance the analysis of MRI scans.
AI-Driven Augmented Diagnosis
The company leverages artificial intelligence to provide augmented diagnoses, particularly for musculoskeletal (MSK) conditions. Their technology aims to improve diagnostic quality through greater sensitivity and specificity.
Musculoskeletal Conditions Focus
ScanDiags' ImagoPlus Musculoskeletal (MSK) Suite is fully operational, initially launching with a Lumbar Spine module. Modules for Knee, Shoulder, and Hip are in development for future releases, indicating a strong focus on orthopedic conditions.
Standardized & Automated Reporting
Their platform generates standardized diagnostic reports through a fully automated process, aiming to unburden clinicians, increase workflow capacity, and reduce healthcare system costs.
Key Differentiator: Platform Independence
ScanDiags' ImagoPlus platform is compatible with all MRI hardware platforms and integrates seamlessly into existing radiology operations. It is designed to be manufacturer-, PACS-, and parameter-independent.
Technology Stack: Deep Learning & Machine Learning
The core of their technology combines deep learning, image analysis, and regression-based machine learning methods, specifically utilizing Supervised Deep Convolutional Neural Networks (DCNN) for classification and segmentation.
Clinical Validation & Regulatory Progress
ScanDiags has completed successful clinical trials in Switzerland with results published in European medical journals. They have also submitted for FDA clearance in the US for their Ortho L-Spine MR-Q software, which is a Class II medical device.
Physician Tip

For physicians, ScanDiags AG stands out by offering an AI-powered adjunct tool that significantly augments MRI analysis, rather than replacing clinical judgment. The ImagoPlus platform aims to unburden clinicians by automating tedious measurement tasks and generating standardized, high-quality diagnostic reports, thereby freeing up more time for patient interaction. Its manufacturer-, PACS-, and parameter-independent design ensures broad compatibility and seamless integration into existing radiology workflows. The rigorous clinical validation and ongoing regulatory efforts, including a 510(k) submission to the FDA for their Lumbar Spine module, underscore their commitment to accuracy and reliability in a clinical setting. This technology promises to improve diagnostic quality through enhanced sensitivity and specificity, ultimately contributing to better patient outcomes and potentially saving lives.

ScanDiags' ImagoPlus platform is designed for seamless integration into existing radiology operations, being compatible with all MRI hardware platforms and independent of specific manufacturers, PACS systems, and parameters. The software uploads DICOM data files from existing equipment and sends approved measurement results back to the PACS system as a PDF report, ensuring a smooth workflow without direct interfacing with MRI or data collection equipment.

Products by ScanDiags AG

1 product in the directory

ScanDiags Ortho L-Spine MR-Q
ScanDiags AG
Radiology & Imaging AI
ScanDiags Ortho L-Spine MR-Q is an FDA-cleared AI-powered Software as a Medical Device (SaMD) that provides quantitative analysis and visualization of lumbar spine MRI images. It uses deep learning for semi-automatic segmentation and measurement of anatomical structures, generating radiologist-reviewed reports for PACS integration.

What the Web Says

ScanDiags AG, an AI-driven healthcare company, focuses on augmented diagnosis from musculoskeletal MRI. Their product, ScanDiags, is designed to be manufacturer-, PACS-, and parameter-independent, aiming for human-level or superior precision. The company collaborates with leading public and private hospitals in Switzerland and has its solutions validated by globally recognized clinicians and radiologists.

Overall: Mixed

Strengths

  • AI for augmented diagnosis from musculoskeletal MRI
  • Manufacturer-, PACS-, and parameter-independent
  • Performs at or above human precision
  • Built in collaboration with leading Swiss hospitals
  • Validated by globally recognized clinicians and radiologists
  • Aims to interpret MRI of all body regions for orthopedic conditions

Limitations

  • No specific product or employer reviews found on G2, Glassdoor, Capterra, or Reddit for ScanDiags AG.
  • General review platforms like Trustpilot for G2 and Capterra show mixed to negative feedback regarding customer service and user experience for those platforms themselves, not ScanDiags AG.

Based on reviews from: Microsoft Marketplace, Trustpilot

Last updated: 2026-07-19

Videos

News, demos, and interviews about ScanDiags AG.

Loading videos...

Videos load interactively. If none appear, search YouTube for ScanDiags AG →

View all on YouTube

Frequently Asked Questions

ScanDiags AG's core product is the ImagoPlusu2122 artificial intelligence software platform, designed to amplify the precision and efficiency of MRI analysis. It provides immediate data detection, quantification, and clinical insights, generating standardized diagnostic reports in an automated process. While the Musculoskeletal (MSK) Suite is fully operational with a Lumbar Spine module and upcoming Knee, Shoulder, and Hip modules, the company is also developing Neurological and Cardiovascular pathology suites to expand its diagnostic capabilities.
The ImagoPlus Musculoskeletal (MSK) Suite is currently operational, launching with a Lumbar Spine module, with Knee, Shoulder, and Hip modules being finalized for future releases. This suite aids in the augmented diagnosis of various orthopedic conditions. ScanDiags is actively expanding the ImagoPlus platform to incorporate Neurological and Cardiovascular pathology suites, which are currently under development for anticipated release in 2026 and 2027.
ScanDiags is actively pursuing regulatory clearance from the US Food and Drug Administration (FDA), with a 510k submission in preparation following four successful clinical trials in Switzerland. Their 'ScanDiags Ortho L-Spine MR-Q' software is classified as Software as a Medical Device (SaMD) and is HIPAA Compliant, ensuring data privacy by preventing unauthorized access and encrypting data in transfer.
While specific pricing details are not publicly disclosed, ScanDiags' ImagoPlus platform aims to reduce healthcare system costs and increase workflow capacity by providing standardized diagnostic reports in a fully automated process. The company emphasizes its ability to unburden clinicians at the point of care, suggesting a value-based proposition for healthcare providers.
ScanDiags' ImagoPlus platform is designed for seamless integration into existing radiology operations and is compatible with all MRI hardware platforms and common scan protocols, requiring no extensive IT projects or protocol adjustments. The software includes a DICOM Viewer for reviewing and editing results, which are then exported as PDF reports to the clinician's PACS system, with the radiologist retaining responsibility for final approval.
ScanDiags AG has partnered with OMNIA Global, an entrepreneurial Swiss family office, to support its engagement with capital markets, business development, financing, and global commercialization activities. This partnership aims to expedite the growth and market reach of ScanDiags' innovative products.
ScanDiags AG, with its research and development group based in Zurich, Switzerland, and headquarters in Vancouver, Canada, was initiated in 2015 (originally as Balzano Informatik AG). The company is actively engaged in product validation and verification, including clinical trials and preparing for FDA clearance, and has secured a partnership with OMNIA Global to support its financial and commercialization objectives, indicating a focus on growth and market presence.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.